Plasma leptin and C-peptide concentrations were associated with an increased risk of CRC (confounder-adjusted HR for a one-unit increment: plasma leptin, 1.59; 95% CI, 1.00–2.54; plasma C-peptide, 1.36; 95% CI, 0.97–1.91). This evidence concerns the gene LEP and colorectal carcinoma.